Trial
NCT06586658
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shanghai Changzheng Hospital
Collaborators
Shanghai First Song Biotechnology Co., LTD
Condition
Renal Cell Carcinoma
Intervention
anti-CD70-CAR-T cells
Why stopped
Modifications to the trial design
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-23